source
- STAT+: PhRMA taps Eric Cantor as new CEOEric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.STAT · 24d ago↗ source
- Merck, Daiichi end plans to seek speedy approval of lung cancer ADCThe FDA indicated that the data generated so far wouldn’t support an accelerated clearance of “I-DXd,” a setback that erases an edge Merck and Daiichi had over multiple fast-moving competitors.
- Merck signs up to $2.13 billion deal with SciBrunch for preclinical KRAS inhibitor SPR2015